HK1010081A1 - Methods of preventing or treating allergies - Google Patents

Methods of preventing or treating allergies

Info

Publication number
HK1010081A1
HK1010081A1 HK98110938A HK98110938A HK1010081A1 HK 1010081 A1 HK1010081 A1 HK 1010081A1 HK 98110938 A HK98110938 A HK 98110938A HK 98110938 A HK98110938 A HK 98110938A HK 1010081 A1 HK1010081 A1 HK 1010081A1
Authority
HK
Hong Kong
Prior art keywords
preventing
methods
treating allergies
allergies
treating
Prior art date
Application number
HK98110938A
Other languages
English (en)
Inventor
Erika Isolauri
Leena Metsaniitty
Hannu Korhonen
Seppo Salminen
Eeva-Liisa Syvaoja
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8543602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1010081(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Valio Oy filed Critical Valio Oy
Publication of HK1010081A1 publication Critical patent/HK1010081A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98110938A 1995-06-14 1998-09-24 Methods of preventing or treating allergies HK1010081A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI952926A FI104465B (fi) 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
PCT/FI1996/000350 WO1997000078A1 (fr) 1995-06-14 1996-06-12 Procedes de prevention ou de traitement des allergies

Publications (1)

Publication Number Publication Date
HK1010081A1 true HK1010081A1 (en) 1999-06-11

Family

ID=8543602

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110938A HK1010081A1 (en) 1995-06-14 1998-09-24 Methods of preventing or treating allergies

Country Status (27)

Country Link
US (2) US6506380B1 (fr)
EP (1) EP0833649B2 (fr)
JP (1) JP3983804B2 (fr)
KR (1) KR100494741B1 (fr)
CN (1) CN1154506C (fr)
AR (1) AR003960A1 (fr)
AT (1) ATE230606T1 (fr)
BG (1) BG63153B1 (fr)
BR (1) BR9607827A (fr)
CA (1) CA2224320C (fr)
CZ (1) CZ291904B6 (fr)
DE (1) DE69625690T3 (fr)
DK (1) DK0833649T4 (fr)
EE (1) EE03424B1 (fr)
ES (1) ES2191103T5 (fr)
FI (1) FI104465B (fr)
HK (1) HK1010081A1 (fr)
IL (1) IL122577A0 (fr)
MX (1) MX9710109A (fr)
MY (1) MY113912A (fr)
NO (1) NO321504B1 (fr)
NZ (1) NZ310478A (fr)
PL (1) PL185123B1 (fr)
RO (1) RO120243B1 (fr)
SK (1) SK284245B6 (fr)
WO (1) WO1997000078A1 (fr)
ZA (1) ZA965088B (fr)

Families Citing this family (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
EP0986314B1 (fr) * 1997-06-03 2008-09-10 Ganeden Biotech, Inc. Utilisation d'une bacterie lactique probiotique pour traiter des infections bacteriennes associees a la msn
EP1130093A1 (fr) 1999-01-19 2001-09-05 Maxygen, Inc. Recombinaison d'acides nucléiques moyennant des oligonucléotides
US6998119B1 (en) 1999-08-05 2006-02-14 Nestec S.A. Feed composition containing Bifidobacterium CNCM 1-2168 capable of preventing diarrhea
AU6160200A (en) 1999-08-05 2001-03-05 Societe Des Produits Nestle S.A. New bifidobacteria preventing diarrhea caused by pathogenic bacteria
US20020031787A1 (en) * 2000-02-04 2002-03-14 Maclaren Noel K. Compositions and methods for reducing autoimmunity
FI110668B (fi) 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
WO2002024883A2 (fr) 2000-09-25 2002-03-28 Societe Des Produits Nestle S.A. Bacteries d'acide lactique pouvant reduire la tendance d'un individu a developper des reactions allergiques
EP1593382A1 (fr) 2000-10-06 2005-11-09 Société des Produits Nestlé S.A. Utilisation de bactéries lactiques probiotiques pour équilibrer le système immunitaire de la peau
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1228707A1 (fr) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Utilisation d'alpha-lactalbumine comme agent prébiotique
EP1372412A2 (fr) * 2001-03-09 2004-01-02 Societe Des Produits Nestle S.A. Preparation attenuant les deficits physiologiques lies a l'age et augmentant la longevite
JP2003137804A (ja) * 2001-10-31 2003-05-14 Morinaga Milk Ind Co Ltd インターロイキン−１８誘導剤
EP1364586A1 (fr) * 2002-05-24 2003-11-26 Nestec S.A. Produits probiotiques et tolérance orale
EP1509609B1 (fr) 2002-06-04 2015-04-22 DSM IP Assets B.V. Hydrolysat de proteines riche en tripeptides
WO2004003235A2 (fr) 2002-06-28 2004-01-08 Puleva Biotech, S.A. Souches probiotiques, leur procede de selection, compositions associees et leur utilisation
EP1384483A1 (fr) 2002-07-23 2004-01-28 Nestec S.A. Microorganismes probiotiques pour le traitement du syndrome du colon irritabile par l'amélioration de la fonction neuro-musculaire de l'intestin
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
WO2004112509A2 (fr) * 2003-06-23 2004-12-29 Nestec S.A. Formule nutritionnelle pour fonction de barriere intestinale optimale
CN1942582A (zh) 2004-02-25 2007-04-04 先锋高级育种国际公司 新的苏云金芽孢杆菌晶体多肽、多核苷酸及其组合物
US20050265946A1 (en) * 2004-05-28 2005-12-01 Kao Corporation Elastase inhibitor
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
AU2006233918B2 (en) 2005-04-13 2012-06-21 Nestec S.A. Infant formula with probiotics
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
EP1951064B2 (fr) * 2005-11-14 2020-05-13 Société des Produits Nestlé S.A. Promotion de tolerance orale a base de proteines glycatees
PL1986669T3 (pl) 2006-02-15 2012-09-28 Nestec Sa Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
WO2007101675A1 (fr) 2006-03-07 2007-09-13 Nestec S.A. Mélange synbiotique
MY180578A (en) * 2006-06-15 2020-12-02 Nestec Sa Induction of tolerance to egg proteins
RU2468807C2 (ru) * 2007-02-28 2012-12-10 Мед Джонсон Нутришен Компани Детское питание, содержащее инактивированный пробиотик
EP1974734A1 (fr) † 2007-03-28 2008-10-01 Nestec S.A. Probiotiques pour la réduction du risque d'obésité
EP1974743A1 (fr) 2007-03-28 2008-10-01 Nestec S.A. Probiotiques pour l'amélioration du microbiote intestinal
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
EP1974735A1 (fr) 2007-03-28 2008-10-01 Nestec S.A. Réduction du risque de diarrhée
JP2010536385A (ja) 2007-08-24 2010-12-02 コデクシス， インコーポレイテッド （ｒ）−３−ヒドロキシチオランの立体選択的生成のための改善されたケトレダクターゼポリペプチド
EP2072052A1 (fr) 2007-12-17 2009-06-24 Nestec S.A. Prévention d'infections opportunistes dans des sujets dont l'immunité est fragilisée
US9227777B2 (en) 2008-01-24 2016-01-05 Nestec S.A. Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
EP2244734B1 (fr) 2008-02-01 2016-05-04 Murdoch Childrens Research Institute Procédé d'induction de tolérance à un allergène
BRPI0909289A2 (pt) 2008-03-14 2015-08-04 Nestec Sa Mistura simbiótica
EP2127661A1 (fr) 2008-05-27 2009-12-02 Nestec S.A. Probiotiques pour l'amélioration du microbiote intestinal
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
CA2726850C (fr) 2008-06-13 2015-06-02 Codexis, Inc. Procede de synthese de variants de polynucleotides
CN102816106A (zh) 2008-06-24 2012-12-12 默沙东公司 用于制备基本上立体异构纯的稠合二环脯氨酸化合物的生物催化方法
EP2147678A1 (fr) 2008-07-21 2010-01-27 Nestec S.A. Probiotiques pour augmenter la sécrétion IgA pour les enfants nés par césarienne
SI2329013T1 (sl) 2008-08-27 2016-03-31 Codexis, Inc. Polipeptidi ketoreduktaze za proizvodnjo 3-aril-3-hidroksipropanamina iz 3-aril-3-ketopropanamina
CN102341494B (zh) 2009-01-08 2014-10-15 科德克希思公司 转氨酶多肽
WO2010107644A2 (fr) 2009-03-17 2010-09-23 Codexis, Inc. Variantes d'endoglucanases et polynucléotides connexes
CA2757040C (fr) 2009-03-31 2016-02-09 Codexis, Inc. Endoglucanases ameliorees
US8357523B2 (en) 2009-06-16 2013-01-22 Codexis, Inc. Beta-glucosidase variant enzymes and related polynucleotides
CN102482648B (zh) 2009-06-22 2014-12-10 科德克希思公司 酮还原酶介导的产生α氯代醇的立体选择性途径
US8614081B2 (en) 2009-07-23 2013-12-24 Codexis, Inc. Nitrilase biocatalysts
TR201807156T4 (tr) * 2009-08-18 2018-06-21 Nestec Sa Bifidobacterium longum suşları içeren ve özellikle bebeklerde ve çocuklarda gıda alerjisi semptomlarını azaltan bir besin bileşimi.
CN102695427B (zh) * 2009-08-18 2016-04-13 雀巢产品技术援助有限公司 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物
EP2467473B1 (fr) 2009-08-19 2016-03-23 Codexis, Inc. Polypeptides de kétoréductase pour la préparation de phényléphrine
CA2772859C (fr) 2009-09-04 2015-05-26 Codexis, Inc. Cellulases cbh2 variantes et polynucleotides apparentes
EP2295535A1 (fr) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Matériau probiotique
SG179197A1 (en) 2009-09-18 2012-04-27 Codexis Inc Reduced codon mutagenesis
EP2504431A4 (fr) 2009-11-25 2013-10-16 Codexis Inc Variants de bêta-glucosidase recombinante de thermoascus aurientiacus pour la production de sucres fermentables à partir de biomasse cellulosique
PL2504017T3 (pl) 2009-11-25 2014-06-30 Codexis Inc Rekombinacyjne warianty beta-glukozydazy do wytwarzania rozpuszczalnych cukrów z biomasy celulozowej
SI2510089T1 (sl) 2009-12-08 2015-12-31 Codexis, Inc. Sinteza prazolnih spojin
BR112012013766A2 (pt) 2009-12-08 2015-09-15 Nestec Sa "fórmula infantil com probióticos e componentes de membrana do glóbulo de gordura do leite"
WO2011082304A1 (fr) 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Modification génétique de la résistance de plantes à des maladies provoquées par des agents pathogènes
EP2566497B1 (fr) 2010-05-04 2015-07-29 Codexis, Inc. Biocatalyseurs pour la synthèse d'ézétimibe
EP2569331A1 (fr) 2010-05-10 2013-03-20 Perseid Therapeutics LLC Polypeptides inhibiteurs de vla4
CA2798937A1 (fr) 2010-05-28 2011-12-01 Codexis, Inc. Fermentation de pentose par micro-organisme recombinant
US8852900B2 (en) 2010-06-17 2014-10-07 Codexis, Inc. Biocatalysts and methods for the synthesis of (S)-3-(1-aminoethyl)-phenol
EP2585587B1 (fr) 2010-06-28 2017-08-09 Codexis, Inc. Acyle réductases formant des alcools gras (far) et procédés pour les utiliser
CA2803952C (fr) 2010-06-30 2020-03-24 Codexis, Inc. Anhydrases carboniques de classe beta tres stables et utiles dans des systemes de capture du carbone
US9006460B2 (en) 2010-08-16 2015-04-14 Cardiome International Ag Process for preparing aminocyclohexyl ether compounds
ES2623288T3 (es) 2010-08-20 2017-07-10 Codexis, Inc. Uso de proteínas de la familia de glicólido hidrolasa 61 en el procesamiento de celulosa
EP2649187B1 (fr) 2010-12-08 2017-11-22 Codexis, Inc. Biocatalyseurs et procédés de synthèse de l'armodafinil
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EP2691517A4 (fr) 2011-03-30 2015-04-22 Codexis Inc Fermentation des pentoses par un micro-organisme recombinant
HUE038800T2 (hu) 2011-04-13 2018-11-28 Codexis Inc Biokatalitikus eljárás eszlikarbazepin és ennek analógjai elõállítására
UA111078C2 (uk) * 2011-05-03 2016-03-25 Нестек С.А. Гідролізат білкового субстрату і спосіб його виготовлення
BR112013033614A2 (pt) 2011-06-30 2018-05-29 Codexis Inc fermentação de pentose por microorganismo recombinante
WO2013028701A1 (fr) 2011-08-22 2013-02-28 Codexis, Inc. Variants protéiques des glycosides hydrolases gh61 et cofacteurs renforçant l'activité des gh61
EP2753640B1 (fr) 2011-09-08 2016-03-09 Codexis, Inc. Biocatalyseurs et procédés pour synthèse de lactames substitués
US20130084608A1 (en) 2011-09-30 2013-04-04 Codexis, Inc. Fungal proteases
WO2013052101A1 (fr) * 2011-10-03 2013-04-11 Kelly Foods Corporation Composition probiotique pour animaux domestiques, et procédé d'obtention de celle-ci
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
US9139819B2 (en) 2011-11-18 2015-09-22 Codexis, Inc. Biocatalysts for the preparation of hydroxy substituted carbamates
BR112014015030A2 (pt) 2011-12-20 2017-06-13 Codexis Inc variantes da endoflucanase 1b (eg1b)
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
HUE036985T2 (hu) 2012-03-23 2018-08-28 Codexis Inc Biokatalizátor és eljárások triptamin és triptamin-analógok származékainak szintetizálására
EP2847327B1 (fr) 2012-05-08 2018-12-26 Codexis, Inc. Biocatalyseurs et procédés pour l'hydroxylation de composés chimiques
US9193957B2 (en) 2012-05-11 2015-11-24 Codexis, Inc. Engineered imine reductases and methods for the reductive animation of ketone and amine compounds
WO2013188313A2 (fr) 2012-06-11 2013-12-19 Codexis, Inc. Xylanases et xylosidases fongiques
WO2014081605A1 (fr) 2012-11-20 2014-05-30 Codexis, Inc. Fermentation de pentose par un microorganisme recombiné
EP3406594A1 (fr) 2012-12-07 2018-11-28 Merck Sharp & Dohme Corp. Procédé de transamination biocatalytique
WO2014099730A1 (fr) 2012-12-21 2014-06-26 Codexis, Inc. Biocatalyseurs génétiquement modifiés et procédés de synthèse d'amines chirales
JP6486835B2 (ja) 2013-01-18 2019-03-20 コデクシス， インコーポレイテッド カルバペネム合成に有用な人口生体触媒
JP6436541B2 (ja) 2013-02-28 2018-12-12 コデクシス， インコーポレイテッド 工業的生体触媒作用のための操作されたトランスアミナーゼポリペプチド
CN103355405A (zh) * 2013-04-07 2013-10-23 苏州旭优食品科技有限公司 一种低过敏性含乳制品的加工工艺
WO2014172541A2 (fr) 2013-04-18 2014-10-23 Codexis, Inc. Polypeptides de phénylalanine ammoniac-lyase modifiés
CN106232619B (zh) 2013-11-13 2022-09-09 科德克希思公司 工程化的亚胺还原酶和用于酮和胺化合物的还原胺化的方法
DK3145536T3 (da) 2014-04-16 2022-01-03 Codexis Inc Modificeret tyrosinammoniaklyase
EP3167052B1 (fr) 2014-07-09 2020-01-01 Codexis, Inc. Variants de p450 bm3 ayant une activité améliorée
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10370648B2 (en) 2014-11-25 2019-08-06 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
PT3237621T (pt) 2014-12-22 2023-07-20 Codexis Inc Variantes da alfa-galactosidase humana
ES2830725T3 (es) 2015-02-10 2021-06-04 Codexis Inc Polipéptidos cetoreductasa para la síntesis de compuestos quirales
SG11201708356PA (en) 2015-05-07 2017-11-29 Codexis Inc Penicillin-g acylases
DK3319987T3 (da) 2015-07-07 2021-06-21 Codexis Inc Nye p450-bm3-varianter med forbedret aktivitet
CN109715793A (zh) 2016-05-05 2019-05-03 科德克希思公司 青霉素-g 酰化酶
CN109715817B (zh) 2016-06-09 2022-12-09 科德克希思公司 用于化合物的羟基化的生物催化剂和方法
EA201990035A1 (ru) 2016-06-15 2019-06-28 Кодексис, Инк. Генно-инженерные бета-глюкозидазы и способы глюкозилирования
WO2018038906A1 (fr) 2016-08-26 2018-03-01 Codexis, Inc. Imines réductases manipulées et procédés d'amination réductrice de composés cétoniques et aminés
KR20190102063A (ko) 2017-01-05 2019-09-02 코덱시스, 인코포레이티드 페니실린 ｇ 아실라아제
WO2018144679A2 (fr) 2017-02-03 2018-08-09 Codexis, Inc. Glycosyl transférases modifiées et procédés de glucosylation de glycosides de stéviol
MY196740A (en) 2017-02-13 2023-05-03 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides
CA3060715A1 (fr) 2017-04-24 2018-11-01 Tesaro, Inc. Procedes de fabrication de niraparib
CN110831618B (zh) 2017-04-27 2023-08-25 科德克希思公司 酮还原酶多肽及多核苷酸
AU2018266606A1 (en) 2017-05-08 2019-11-14 Codexis, Inc. Engineered ligase variants
WO2018231462A1 (fr) 2017-06-14 2018-12-20 Codexis, Inc. Polypeptides transaminase modifiés destinés à une biocatalyse industrielle
US11643642B2 (en) 2017-06-27 2023-05-09 Codexis, Inc. Penicillin-g acylases
JP2020530267A (ja) 2017-06-30 2020-10-22 コデクシス， インコーポレイテッド Ｔ７ ｒｎａポリメラーゼバリアント
US10793841B2 (en) 2017-06-30 2020-10-06 Codexis, Inc. T7 RNA polymerase variants
JP2021502068A (ja) 2017-11-07 2021-01-28 コデクシス， インコーポレイテッド トランスグルタミナーゼバリアント
US11015180B2 (en) 2017-12-13 2021-05-25 Codexis, Inc. Carboxyesterase polypeptides for amide coupling
CN111465688A (zh) 2017-12-13 2020-07-28 葛兰素史密斯克莱知识产权发展有限公司 羧酸酯酶催化剂
EP3807409A4 (fr) 2018-06-12 2022-08-03 Codexis, Inc. Tyrosine ammonia-lyase modifiée
SG11202012111UA (en) 2018-07-09 2021-01-28 Codexis Inc Engineered purine nucleoside phosphorylase variant enzymes
CN112601821A (zh) 2018-07-09 2021-04-02 科德克希思公司 工程化磷酸戊糖变位酶变体酶
US10889806B2 (en) 2018-07-09 2021-01-12 Codexis, Inc. Engineered pantothenate kinase variant enzymes
KR20210030379A (ko) 2018-07-09 2021-03-17 코덱시스, 인코포레이티드 조작된 갈락토스 옥시다제 변이 효소
WO2020014048A1 (fr) 2018-07-09 2020-01-16 Codexis, Inc. Désoxyribose-phosphate aldolases modifiées
US11198861B2 (en) 2018-07-12 2021-12-14 Codexis, Inc. Engineered phenylalanine ammonia lyase polypeptides
EP3830106A4 (fr) 2018-07-30 2022-07-06 Codexis, Inc. Glycosyltransférases modifiées et procédés de glucosylation de glycosides de stéviol
SG11202103639SA (en) 2018-10-29 2021-05-28 Codexis Inc Engineered dna polymerase variants
AU2019397401A1 (en) 2018-12-14 2021-06-17 Codexis, Inc. Engineered tyrosine ammonia lyase
US11427813B2 (en) 2018-12-20 2022-08-30 Codexis, Inc. Human alpha-galactosidase variants
EP4003061B1 (fr) 2019-07-23 2024-04-24 FrieslandCampina Nederland B.V. Composition nutritionnelle comprenant de la matière grasse du lait et de l'immunoglobuline
JP2022545718A (ja) 2019-08-30 2022-10-28 コデクシス， インコーポレイテッド 操作されたリパーゼ改変体
WO2021050348A1 (fr) 2019-09-12 2021-03-18 Codexis, Inc. Activité de la peroxydase envers la 10-acétyl -3,7-dihydroxyphénoxazine
JP2022551598A (ja) 2019-10-02 2022-12-12 アボット ダイアベティス ケア インコーポレイテッド タンパク質スイッチによる分析物の検出
CA3165484A1 (fr) 2019-12-20 2021-06-24 Codexis, Inc. Variants d'alpha-glucosidase acide modifies
EP4133064A2 (fr) 2020-04-10 2023-02-15 Codexis, Inc. Polypeptides de transaminase modifiés
MX2023002421A (es) 2020-08-28 2023-05-18 Codexis Inc Variantes de amilasa modificadas geneticamente.
JP2023539632A (ja) 2020-08-28 2023-09-15 コデクシス， インコーポレイテッド 操作されたプロテアーゼバリアント
CA3201757A1 (fr) 2020-12-11 2022-06-16 Mathias Schuetz Genes recombines d'enzyme activatrice d'acyle (aae) pour une biosynthese amelioree des cannabinoides et des precurseurs de cannabinoides
EP4262804A2 (fr) 2020-12-18 2023-10-25 Codexis, Inc. Enzymes variantes d'uridine phosphorylase modifiées
CA3215105A1 (fr) 2021-04-02 2022-10-06 Codexis, Inc. Enzymes variantes d'acetate kinase modifiees
CN117120600A (zh) 2021-04-02 2023-11-24 科德克希思公司 工程化腺苷酸激酶变体酶
IL305922A (en) 2021-04-02 2023-11-01 Codexis Inc Transgenic enzymes of variant guanylate kinase
US20220325285A1 (en) 2021-04-02 2022-10-13 Codexis, Inc. ENGINEERED CYCLIC GMP-AMP SYNTHASE (cGAS) VARIANT ENZYMES
CA3227215A1 (fr) 2021-07-30 2023-02-02 Trish Choudhary Polypeptides de prenyltransferase recombinants mis au point pour une biosynthese amelioree de cannabinoides
WO2023023621A1 (fr) 2021-08-19 2023-02-23 Willow Biosciences, Inc. Polypeptides de cyclase d'acide olivétolique recombinés modifiés pour une biosynthèse améliorée de cannabinoïdes
WO2023069921A1 (fr) 2021-10-19 2023-04-27 Epimeron Usa, Inc. Polypeptides de thca synthase recombinants modifiés pour une biosynthèse améliorée de cannabinoïdes
WO2024040020A1 (fr) 2022-08-15 2024-02-22 Absci Corporation Enrichissement de cellule spécifique à une activité d'affinité quantitative

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886288A (en) * 1970-06-15 1975-05-27 Swift & Co Cheese manufacture using highly active proteolytic enzymes
JPS5279086A (en) 1975-12-25 1977-07-02 Nippon Soda Co Ltd Preparation of antibiotic tunicamycin
JPS5279083A (en) * 1975-12-26 1977-07-02 Morinaga Milk Industry Co Ltd Production of protein decomposed substance not having bitterness and antigen property
JPS6041751B2 (ja) 1976-06-22 1985-09-18 ジエコ−株式会社 デジタル電子時計
JPS548785A (en) 1977-06-21 1979-01-23 Kikkoman Corp Preparation of protein hydrolyzate
US4839281A (en) † 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK589785A (da) 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
ATE84680T1 (de) † 1987-12-23 1993-02-15 Nestle Sa Verfahren zur herstellung eines molkeeiweisshydrolysates und eines hypoallergenen nahrungsmittels.
DD281540A5 (de) * 1988-08-08 1990-08-15 Berlin Chemie Veb Verfahren zur herstellung von nutritiva
ES2063882T5 (es) † 1989-10-02 2001-12-01 Novartis Nutrition Ag Hidrolizados de proteinas.
JP3071877B2 (ja) † 1991-06-27 2000-07-31 財団法人糧食研究会 経口寛容誘導能を有する低アレルゲン性酵素分解ペプチド組成物
US5952034A (en) * 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
ATE161181T1 (de) * 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
FI94089C (fi) 1992-12-10 1995-07-25 Valio Oy Menetelmä allergiaa aiheuttavien yhdisteiden poistamiseksi proteiinipitoisista koostumuksista
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
GB9312369D0 (en) * 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
AU1076595A (en) † 1993-11-23 1995-06-13 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Also Published As

Publication number Publication date
DE69625690T3 (de) 2009-12-24
NO321504B1 (no) 2006-05-15
EE03424B1 (et) 2001-06-15
CA2224320C (fr) 2012-03-20
ES2191103T5 (es) 2009-11-03
NZ310478A (en) 2000-01-28
CZ291904B6 (cs) 2003-06-18
EE9700339A (et) 1998-06-15
IL122577A0 (en) 1998-06-15
DK0833649T3 (da) 2003-04-07
CN1154506C (zh) 2004-06-23
JP3983804B2 (ja) 2007-09-26
DE69625690D1 (de) 2003-02-13
CN1187772A (zh) 1998-07-15
FI952926A (fi) 1996-12-15
EP0833649B1 (fr) 2003-01-08
DK0833649T4 (da) 2009-07-20
DE69625690T2 (de) 2003-11-06
NO975832L (no) 1997-12-11
JPH11510791A (ja) 1999-09-21
RO120243B1 (ro) 2005-11-30
CA2224320A1 (fr) 1997-01-03
CZ399797A3 (cs) 1998-06-17
AU6127896A (en) 1997-01-15
AR003960A1 (es) 1998-09-30
SK171597A3 (en) 1998-11-04
BR9607827A (pt) 1999-11-30
US7172756B2 (en) 2007-02-06
EP0833649A1 (fr) 1998-04-08
PL324010A1 (en) 1998-04-27
PL185123B1 (pl) 2003-02-28
ES2191103T3 (es) 2003-09-01
BG63153B1 (bg) 2001-05-31
MX9710109A (es) 1998-10-31
US20030113340A1 (en) 2003-06-19
WO1997000078A1 (fr) 1997-01-03
MY113912A (en) 2002-06-29
AU710126B2 (en) 1999-09-16
KR100494741B1 (ko) 2005-09-30
FI952926A0 (fi) 1995-06-14
KR19990022914A (ko) 1999-03-25
FI104465B (fi) 2000-02-15
ZA965088B (en) 1997-01-22
BG102144A (en) 1998-12-30
SK284245B6 (sk) 2004-12-01
US6506380B1 (en) 2003-01-14
EP0833649B2 (fr) 2009-06-03
ATE230606T1 (de) 2003-01-15
NO975832D0 (no) 1997-12-11

Similar Documents

Publication Publication Date Title
HK1010081A1 (en) Methods of preventing or treating allergies
PL324284A1 (en) Methods of treating diabetes
GB9617780D0 (en) Method of treatment
GB9715295D0 (en) Novel method of treatment
GB9712866D0 (en) Novel method of treatment
PL327600A1 (en) Method of treating depressions
GB9707693D0 (en) Novel method of treatment
GB9715298D0 (en) Novel method of treatment
ZA965346B (en) Methods of treating neuropeptide Y-associated conditions.
GB9715306D0 (en) Novel method of treatment
GB9618341D0 (en) Method of treatment
ZA973988B (en) Method of treatment
GB9507825D0 (en) Method of treatment
GB9415902D0 (en) Method of treatment
GB9407335D0 (en) Method of treatment
GB9504444D0 (en) Treatment of eczema
GB9414652D0 (en) Method of treatment
GB9503200D0 (en) Methods of treatment
EP0705104A4 (fr) Therapie anticancereuse
GB9508963D0 (en) Method of treatment
GB9502514D0 (en) Method of treatment
GB9523655D0 (en) Method of treatment
GB9500396D0 (en) Method of treatment
GB9500723D0 (en) Method of treatment
GB9516795D0 (en) Method of treatment

Legal Events

Date Code Title Description
PF Patent in force
AM43 Amendment of standard patent following opposition or revocation proceedings in the designated patent office (acc. sect 43 patent ordinance)
PE Patent expired

Effective date: 20160611